ACCESSION: MSBNK-SMB_Measured-HSA015P0134003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 16
COMMENT: RAW_SPEC {'EL16_pos_2722': {'bp': 224299.0, 'sum': 863874.0}, 'EL04_pos_2747': {'bp': 215248.0, 'sum': 793120.0}, 'EL08_pos_2732': {'bp': 209122.0, 'sum': 818905.0}, 'EL24_pos_2771': {'bp': 206953.0, 'sum': 960277.0}, 'EL18_pos_2734': {'bp': 201244.0, 'sum': 796830.0}, 'EL02_pos_2734': {'bp': 199180.0, 'sum': 808270.0}, 'EL09_pos_2715': {'bp': 198070.0, 'sum': 758031.0}, 'EL07_pos_2722': {'bp': 192335.0, 'sum': 721000.0}, 'EL01_pos_2733': {'bp': 190614.0, 'sum': 758077.0}, 'EL19_pos_2745': {'bp': 189907.0, 'sum': 787595.0}, 'EL20_pos_2722': {'bp': 186283.0, 'sum': 747198.0}, 'EL11_pos_2717': {'bp': 185377.0, 'sum': 728846.0}, 'EL21_pos_2722': {'bp': 179943.0, 'sum': 712152.0}, 'EL17_pos_2722': {'bp': 173928.0, 'sum': 710062.0}, 'EL14_pos_2728': {'bp': 167781.0, 'sum': 665297.0}, 'EL10_pos_2727': {'bp': 160507.0, 'sum': 632798.0}}
COMMENT: RETENTION_TIME_STDEV 0.021
COMMENT: PRECURSOR_M/Z_RAW 134.096640
COMMENT: PRECURSOR_M/Z_STDEV 0.000039
COMMENT: PRECURSOR_IN_MS1 mz 134.096453; int 33.478; delta(ppm) 0.734482
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.210; C9H11N; [M+H]+; delta(ppm) 0.210385
COMMENT: PROPOSED_MF MS-FINDER 4.591; C9H11N; [M+H]+; delta(ppm) 0.202912
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.150; C9H11N; [M+H]+; delta(ppm) 0.202912
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.741; C6H12FNO; [M+H]+; delta(ppm) -8.318153
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.007; C5H14N2P; [M+H]+; delta(ppm) -2.102164
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.930; C9H11N; [M+H]+; delta(ppm) 0.202912
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.070; C6H12FNO; [M+H]+; delta(ppm) -8.318153
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.841; FIRXFHJQGIIJDB-UHFFFAOYSA-N; [M+H]+; CN1CCC2=CC=CC=C21
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.822; HOAJAZVXWNQMOV-UHFFFAOYSA-N; [M+H]+; CC1=NC2=C(CCC2)C=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.737; XJEVHMGJSYVQBQ-UHFFFAOYSA-N; [M+H]+; C1CC2=CC=CC=C2C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.726; QRWRJDVVXAXGBT-JLDDOWRYNA-N; [M+H]+; C[C@@H]1CC2=C(N1)C=CC=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.708; YEYCASGOSICVMZ-UHFFFAOYSA-N; [M+H]+; CC(C)=NC1=CC=CC=C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.595; UWYZHKAOTLEWKK-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-Tetrahydroisoquinoline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.592; AELCINSCMGFISI-YGPZHTELSA-N; [M+H]+; Tranylcypromine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.321; YEYCASGOSICVMZ-UHFFFAOYSA-N; [M+H]+; UNPD118195
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.306; LMHHFZAXSANGGM-UHFFFAOYSA-N; [M+H]+; Aminoindane??(2-AI)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.301; QRWRJDVVXAXGBT-JLDDOWRYNA-N; [M+H]+; UNPD120011
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.177; HOAJAZVXWNQMOV-UHFFFAOYSA-N; [M+H]+; UNPD142479
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.135; XJEVHMGJSYVQBQ-UHFFFAOYSA-N; [M+H]+; 2,3-dihydro-1H-inden-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.130; AYEYWOSWHMHDSZ-JLDDOWRYNA-N; [M+H]+; UNPD29362
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.106; FIRXFHJQGIIJDB-UHFFFAOYSA-N; [M+H]+; 1-methyl-2,3-dihydroindole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.057; LBUJPTNKIBCYBY-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.949; YQDGQEKUTLYWJU-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydroquinoline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.620; LQFLWKPCQITJIH-UHFFFAOYSA-N; [M+H]+; N-Allyl-Aniline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.553; RDAFNSMYPSHCBK-UHFFFAOYSA-N; [M+H]+; 3-phenylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FIRXFHJQGIIJDB-UHFFFAOYSA-N; [M+H]+; 1-methyl-2,3-dihydroindole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; AYEYWOSWHMHDSZ-JLDDOWRYNA-N; [M+H]+; UNPD29362
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; HOAJAZVXWNQMOV-UHFFFAOYSA-N; [M+H]+; UNPD142479
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; QRWRJDVVXAXGBT-JLDDOWRYNA-N; [M+H]+; UNPD120011
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.940; YEYCASGOSICVMZ-UHFFFAOYSA-N; [M+H]+; UNPD118195
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.671; LQFLWKPCQITJIH-UHFFFAOYSA-N; [M+H]+; N-Allyl-Aniline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; UWYZHKAOTLEWKK-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-Tetrahydroisoquinoline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.654; LBUJPTNKIBCYBY-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.637; AELCINSCMGFISI-YGPZHTELSA-N; [M+H]+; Tranylcypromine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.637; LMHHFZAXSANGGM-UHFFFAOYSA-N; [M+H]+; Aminoindane??(2-AI)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.637; XJEVHMGJSYVQBQ-UHFFFAOYSA-N; [M+H]+; 2,3-dihydro-1H-inden-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.637; YQDGQEKUTLYWJU-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydroquinoline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RDAFNSMYPSHCBK-UHFFFAOYSA-N; [M+H]+; 3-phenylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.947; AELCINSCMGFISI-DTWKUNHWSA-N; [M+H]+; (1R,2S)-2-phenylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.387; UWYZHKAOTLEWKK-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroisoquinoline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.235; LBUJPTNKIBCYBY-UHFFFAOYSA-N; [M+H]+; 1,2,3,4-tetrahydroquinoline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.386; QRWRJDVVXAXGBT-UHFFFAOYSA-N; [M+H]+; 2-methyl-2,3-dihydro-1H-indole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.314; FIRXFHJQGIIJDB-UHFFFAOYSA-N; [M+H]+; 1-methyl-2,3-dihydroindole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.238; HEDYZFYQYPWWCC-UHFFFAOYSA-N; [M+H]+; 2-prop-1-en-2-ylaniline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.228; IIVYBNBDIDWPQV-UHFFFAOYSA-N; [M+H]+; N-ethyl-1-phenylmethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.226; GJFICMVGNQQCEE-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-prop-1-en-2-ylpyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; YQUDMNIUBTXLSX-UHFFFAOYSA-N; [M+H]+; 2-ethenyl-5-ethylpyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; LKLNVHRUXQQEII-UHFFFAOYSA-N; [M+H]+; 5-ethenyl-2,3-dimethylpyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; JFUAVVHABJWSFX-UHFFFAOYSA-N; [M+H]+; 5-methyl-2,3-dihydro-1H-indole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; GYHSHGUXLJLVAR-UHFFFAOYSA-N; [M+H]+; 6-methyl-2,3-dihydro-1H-indole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; BFQARNDIMKOOQQ-UHFFFAOYSA-N; [M+H]+; 3-methyl-2,3-dihydro-1H-indole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; BSRIUSPUGCAPHE-UHFFFAOYSA-N; [M+H]+; 4-methyl-2,3-dihydro-1H-indole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; TZMYQGXSTSSHQV-UHFFFAOYSA-N; [M+H]+; 5-methyl-2,3-dihydro-1H-isoindole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; UWMCJDIBDVFVFT-UHFFFAOYSA-N; [M+H]+; 1-methyl-2,3-dihydro-1H-isoindole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; WHPDSANSNOUOLZ-UHFFFAOYSA-N; [M+H]+; 7-methyl-2,3-dihydro-1H-indole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; YHZHWSFPHDXYBS-UHFFFAOYSA-N; [M+H]+; 4-methyl-2,3-dihydro-1H-isoindole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; HUAHZCFLLQRNRO-UHFFFAOYSA-N; [M+H]+; 3-prop-1-en-2-ylaniline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; NWAQGFVFBBSDAV-UHFFFAOYSA-N; [M+H]+; 2-methyl-3-phenylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; KTXMSWAHSUYOHZ-HWKANZROSA-N; [M+H]+; 3-[(E)-but-1-enyl]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; CXGHVELUDDLRAP-UHFFFAOYSA-N; [M+H]+; 2-methyl-4-prop-1-en-2-ylpyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; PGQILBLSHQORKS-UHFFFAOYSA-N; [M+H]+; 7-methylbicyclo[4.2.0]octa-1,3,5-trien-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; AJIBIWLTIDNRGY-UHFFFAOYSA-N; [M+H]+; 2,5-dimethyl-1-prop-2-ynylpyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.990; LMHHFZAXSANGGM-UHFFFAOYSA-N; [M+H]+; 2,3-dihydro-1H-inden-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.943; OYRBDGKUVUVWRI-UHFFFAOYSA-N; [M+H]+; 1-phenylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; LQFLWKPCQITJIH-UHFFFAOYSA-N; [M+H]+; N-prop-2-enylaniline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.884; XJEVHMGJSYVQBQ-UHFFFAOYSA-N; [M+H]+; 2,3-dihydro-1H-inden-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; YQDGQEKUTLYWJU-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydroquinoline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; HTMGQIXFZMZZKD-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydroisoquinoline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; WAVDSLLYAQBITE-UHFFFAOYSA-N; [M+H]+; (4-ethenylphenyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; OWCNPQKNIWRGLI-UHFFFAOYSA-N; [M+H]+; 2-phenylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; AXYMVRAJICZMIT-UHFFFAOYSA-N; [M+H]+; 3-but-3-enylpyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; UJHRXZWERCGWQW-UHFFFAOYSA-N; [M+H]+; 2-but-3-enylpyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; LEWZOBYWGWKNCK-UHFFFAOYSA-N; [M+H]+; 2,3-dihydro-1H-inden-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.802; XOZGEXKQMVAILQ-UHFFFAOYSA-N; [M+H]+; 3-phenylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.799; CLNGGMJEJSANIE-UHFFFAOYSA-N; [M+H]+; 2-phenylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; LKQAJXTWYDNYHK-VIFPVBQESA-N; [M+H]+; (2S)-2-benzylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.791; RXTJLDXSGNEJIT-UHFFFAOYSA-N; [M+H]+; 2,3-dihydro-1H-inden-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.791; AOTWIFLKURJQGE-UHFFFAOYSA-N; [M+H]+; N-cyclopropylaniline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; UBXDNWVNEZBDBN-UHFFFAOYSA-N; [M+H]+; 4-cyclopropylaniline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; JSKOLQWFMXYJAF-UHFFFAOYSA-N; [M+H]+; 2-cyclopropylaniline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; LKJYNYKTZLTHJN-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylaniline
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; UOQNRKZMXTYCNA-UHFFFAOYSA-N; [M+H]+; 7-bicyclo[4.2.0]octa-1,3,5-trienylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; ZTMRDYCYTDGUEY-UHFFFAOYSA-N; [M+H]+; bicyclo[2.2.2]oct-2-ene-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.343; RDAFNSMYPSHCBK-QPJJXVBHSA-N; [M+H]+; (E)-3-phenylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.143; CRHYPLCALPANOH-UHFFFAOYSA-N; [M+H]+; cuban-1-ylmethanamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C9H12N1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.410
MS$FOCUSED_ION: PRECURSOR_M/Z 134.096453
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0019-0900000000-0d7aebedb9f871afdca0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388071 17.9889 53.039505 1.4329 4.49 0.2923 14 f{C4H5}/4.35ppm,p-C5H7N1
  65.0387017 21.1007 65.039441 1.1378 5.59 0.5500 16 f{C5H5}/1.92ppm,p-C4H7N1
  67.0543738 48.9037 67.055115 0.7755 6.04 0.3429 15 f{C5H7}/2.19ppm,p-C4H5N1
  79.0542828 52.4218 79.055015 0.6578 8.59 0.1692 14 f{C6H7}/0.71ppm,p-C3H5N1
  80.0495474 16.5823 80.050277 1.4741 6.88 0.1978 13 f{C5H6N1}/0.90ppm,p-C4H6
  88.0215079 20.8172 88.022205 1.3065 5.38 0.0420 12 ?
  91.0542316 63.2013 91.054911 0.9665 9.17 0.3676 16 f{C7H7}/0.05ppm,p-C2H5N1
  93.0572713 32.2494 93.057938 0.7307 5.08 0.2676 16 f{C6H7N1}/-0.32ppm,p-C3H5
  93.0698558 32.1251 93.070522 1.0530 5.43 0.2088 16 f{C7H9}/-0.22ppm,p-C2H3N1
  94.0650964 22.9319 94.065756 1.5415 6.43 0.3912 16 f{C6H8N1}/-0.31ppm,p-C3H4
  95.0491598 17.4589 95.049813 0.6733 6.16 0.2448 12 ?
  105.0698715 41.2370 105.070435 0.8375 7.71 -0.2750 15 f{C8H9}/-0.05ppm,p-C1H3N1
  106.0651386 37.7496 106.065692 0.9334 5.96 0.4393 15 f{C7H8N1}/0.12ppm,p-C2H4
  107.0491492 36.7789 107.049692 1.1116 9.22 0.1059 16 ?
  107.0730182 20.9835 107.073561 1.2048 5.12 0.5209 14 f{C7H9N1}/0.63ppm,p-C2H3
  107.0854577 21.0182 107.086000 1.6902 4.63 0.1593 13 f{C8H11}/-0.64ppm,p-C1H1N1
  108.0808449 125.3114 108.081381 0.4904 24.62 -0.0324 16 f{C7H10N1}/0.64ppm,p-C2H2
  118.0651715 41.0271 118.065629 1.3891 7.45 0.6308 14 f{C8H8N1}/0.39ppm,p-C1H4
  119.0730137 22.0030 119.073462 1.1925 3.45 -0.0420 12 f{C8H9N1}/0.53ppm,p-C1H3
  121.0886035 190.9060 121.089033 0.5120 24.73 0.5441 16 f{C8H11N1}/0.02ppm,p-C1H1
  132.0809212 46.4077 132.081231 1.3931 6.23 0.2396 14 f{C9H10N1}/1.10ppm,p-H2
  133.0760149 270.0357 133.076313 0.5035 136.02 0.6618 16 ?
  134.0964613 933.6957 134.096747 0.3132 51.76 1.0000 16 f{C9H12N1}/0.26ppm,p
  135.0441763 38.1690 135.044450 0.8442 10.20 -0.0882 16 ?
  135.0552701 46.7671 135.055544 0.6368 10.60 0.2853 16 ?
  136.0216359 147.6141 136.021899 0.6028 23.15 -0.0471 16 ?
  136.0619097 77.4786 136.062173 1.2421 17.47 -0.1679 15 ?
  136.0757896 176.3358 136.076053 0.5659 20.87 0.3214 15 ?
  136.1121143 999.0000 136.112378 0.2645 11.93 0.6206 16 ?
PK$NUM_PEAK: 29
PK$PEAK: m/z int. rel.int.
  53.038807 17.99 17
  65.038702 21.10 21
  67.054374 48.90 48
  79.054283 52.42 52
  80.049547 16.58 16
  88.021508 20.82 20
  91.054232 63.20 63
  93.057271 32.25 32
  93.069856 32.13 32
  94.065096 22.93 22
  95.049160 17.46 17
  105.069871 41.24 41
  106.065139 37.75 37
  107.049149 36.78 36
  107.073018 20.98 20
  107.085458 21.02 21
  108.080845 125.31 125
  118.065172 41.03 41
  119.073014 22.00 22
  121.088603 190.91 190
  132.080921 46.41 46
  133.076015 270.04 270
  134.096461 933.70 933
  135.044176 38.17 38
  135.055270 46.77 46
  136.021636 147.61 147
  136.061910 77.48 77
  136.075790 176.34 176
  136.112114 999.00 999
//
